Bcl-2 function on the endoplasmic reticulum
Bcl-2 function on the endoplasmic reticulum
批准号:
8207289
负责人:
CLARK W DISTELHORST
金额:
$28.44万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-03 至 2014-12-31
关键词:
Antineoplastic AgentsApoptosisApoptoticCalcineurinCalciumCalcium ChannelCalcium OscillationsCalcium SignalingCalcium ionCell DeathCellsChronic Lymphocytic LeukemiaDockingEndoplasmic ReticulumFluorescence Resonance Energy TransferFundingGoalsGrantITPR1 geneInositolIonsMalignant NeoplasmsMapsMediatingModificationPeptidesPhosphorylationProcessProtein IsoformsProtein Serine/Threonine PhosphataseProteinsResearchResearch SupportResistanceRyanodine Receptor Calcium Release ChannelSiteSpecificityTestingTherapeuticTherapeutic AgentsWorkbasecancer cellcancer therapyinhibitor/antagonistleukemia/lymphomamouse modelpreventpro-apoptotic proteinpublic health relevancereceptorsynergismtherapy designtooltumorigenesis
中文摘要
描述(由申请人提供):Bcl-2蛋白通过抑制细胞凋亡参与肿瘤发生和内在癌症治疗抵抗。该基金支持的研究正在调查Bcl-2作用机制的一个特定方面,即抑制促进细胞凋亡的钙信号。我们发现Bcl-2与肌醇1,4,5-三磷酸受体(IP3R)相互作用,从而抑制ip3诱导的钙升高,IP3R是内质网(ER)上的一个ip3门控钙通道。在目前的资助期内,我们使用FRET在细胞中证明了这种相互作用,并绘制了Bcl-2和IP3R上的相互作用位点。基于这些信息,我们开发了Bcl-2-IP3R相互作用的肽抑制剂肽2。当这种肽被传递到细胞中时,逆转了Bcl-2对促凋亡钙信号的抑制,并引发延长的钙振荡,从而升高促凋亡蛋白Bim。本研究通过研究Bcl-2-IP3R相互作用调节IP3R通道活性从而抑制IP3依赖性钙升高的基本机制来继续这项工作。此外,本研究还探讨了肽2介导的Bcl-2-IP3R相互作用抑制触发钙振荡并增加Bim水平的机制。最后,本提案探讨了靶向Bcl-2- ip3r相互作用的概念,以治疗Bcl-2过表达的癌症,包括慢性淋巴细胞白血病,与其他治疗药物协同作用。
英文摘要
DESCRIPTION (provided by applicant): The Bcl-2 protein contributes to both oncogenesis and intrinsic cancer treatment resistance by inhibiting apoptosis. Research supported by this grant is investigating one particular aspect of Bcl-2's mechanism of action, the inhibition of calcium signals that promote apoptosis. We discovered that Bcl-2 interacts with the inositol 1,4,5-trisphosphate receptor (IP3R), an IP3-gated calcium channel on the endoplasmic reticulum (ER), thus inhibiting IP3-induced calcium elevation. In the current funding period we used FRET to demonstrate this interaction in cells and mapped the interaction sites on both Bcl-2 and the IP3R. Based on this information we developed a peptide inhibitor of Bcl-2-IP3R interaction, Peptide 2. This peptide, when delivered into cells, reverses the inhibition of pro-apoptotic calcium signals by Bcl-2 and triggers prolonged calcium oscillations that elevate the pro-apoptotic protein Bim. The present proposal continues this work by investigating the fundamental mechanism by which Bcl-2-IP3R interaction regulates IP3R channel activity and thus inhibits IP3- dependent calcium elevation. Also, this proposal investigates the mechanism by which Peptide 2-mediated inhibition of Bcl-2-IP3R interaction triggers calcium oscillations and increases Bim levels. Finally, this proposal explores the concept of targeting Bcl-2-IP3R interaction for treatment of Bcl-2 over-expressing cancers, including chronic lymphocytic leukemia, in synergy with other therapeutic agents.
PUBLIC HEALTH RELEVANCE: Bcl-2 is a very important protein that contributes to cancer. It functions to inhibit the death of cells. Therefore, when cancer cells have too much of this protein they fail to die. Thus, the cancer cells accumulate and are resistant to treatments designed to induce cell death. This proposal is for research to better understand how Bcl-2 inhibits cell death. The goal is to understand how Bcl-2 interacts with and regulates channels that conduct calcium ions within cancer cells. These ions are important in mediating cell death. Our research is investigating the hypothesis that Bcl-2 closes these channels and thus prevents the calcium ion from inducing cell death. By understanding this process we may be able to develop new treatments for cancer that overcome the cell death inhibiting function of Bcl-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting PKM2-InsP3R interaction to treat AML
-
批准号:9104123
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2015
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6497990
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6700231
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8458912
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8101377
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7561019
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:6927609
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7031020
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7192491
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6089857
-
项目类别:
-
资助金额:$23.81万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6350441
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6628460
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8596796
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7350157
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:7984883
-
项目类别:
-
资助金额:$13.03万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6626623
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6137701
-
项目类别:
-
资助金额:$22.82万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6489172
-
项目类别:
-
资助金额:$23.83万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:2731899
-
项目类别:
-
资助金额:$22.97万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6342122
-
项目类别:
-
资助金额:$23.32万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: